DALLAS, Jan. 19, 2022 /PRNewswire/ -- Jacobs (NYSE:J) was selected by Johns Hopkins Medicine to provide project management services for the redevelopment of laboratory space on its medical campus in Baltimore, Maryland.
Plans are to renovate The Johns Hopkins Hospital's existing Children's Medical and Surgical Center (CMSC) and construct a new 12-story North Tower addition. The CMSC Building, originally built as the home for Johns Hopkins Children's Center, a 200-bed hospital, has been used for research labs and offices since 2012. The new project will provide innovative spaces for wet and computational laboratories, as well as collaborative spaces for investigators, clinicians and students.
"Jacobs values the opportunity to contribute to the advancement of research for Johns Hopkins Medicine and continue our relationship with one of the premier medical institutions in the world," said Jacobs EVP and President of People & Places Solutions Patrick Hill. "We are committed to supporting the organization's mission of improving the health of the community and the world through setting the standard of excellence in medical education, research and clinical care."
The contract includes project management services for 531,609 square feet of renovations and additions for the CMSC North Tower project, as well as replacement of the existing façade, construction of research laboratories, and a new entrance to The Johns Hopkins Hospital from Monument Street.
Construction is estimated to be completed in the summer of 2026.
Johns Hopkins Medicine is an integrated global health enterprise based in Baltimore, Maryland.
Ranked No. 1 in health care facilities design by Engineering News-Record in 2020, Jacobs is a leader in project management and construction management founded on the successful delivery of some of the world's premier healthcare facilities in the world.
At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With $14 billion in revenue and a talent force of approximately 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector. Visit jacobs.com and connect with Jacobs on Facebook, Instagram, LinkedIn and Twitter.
Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic, including the emergence and spread of variants of COVID-19, the efficacy and availability of vaccines and treatments, and the related reaction of governments on global and regional market conditions and the company's business. For a description of some additional factors that may occur that could cause actual results to differ from our forward-looking statements, see the discussions contained under Item 1 - Business; Item 1A - Risk Factors; Item 3 - Legal Proceedings; and Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recently filed Annual Report on Form 10-K, as well as the company's other filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.
For press/media inquiries:
These press releases may also interest you